Australia’s TPG Telecom Deploys MATRIXX Software to Enable Multiple Brands on a Single, Converged Charging Platform
5.5.2021 03:02:00 EEST | Business Wire | Press release
MATRIXX Software, a global leader in 5G monetization for the communications industry, today announced it has partnered with Australia’s TPG Telecom Limited (ASX: TPG). TPG Telecom operates a number of leading mobile and internet brands including Vodafone, TPG, iiNet, AAPT, Internode and Lebara, providing consumers with a comprehensive portfolio of fixed and mobile products in the Australian telecommunications market.
With their 5G rollout progressing full steam ahead across major Australian cities, TPG Telecom is committed to cementing its place as a strong force for its customers. Looking ahead, as 5G becomes mainstream, TPG Telecom is seeking to unlock new opportunities and offerings resulting from the coming explosion of connected devices. With a goal to improve experience today, while laying the foundation for future innovation, TPG Telecom selected the MATRIXX Digital Commerce Platform to build a flexible, agile service capable of delivering real-time innovation to meet ever-shifting consumer demand.
“At TPG Telecom, the investments we make are designed to provide immediate benefit to our customers today, with an eye towards how we can unlock new opportunities, tomorrow,” said Rob James, Group Chief Digital & Information Officer of TPG Telecom. “Delivering improved value for our shareholders is essential for our success and the MATRIXX platform will enable us with the ability to rapidly innovate and experiment with new monetization models across all of our brands.”
Implemented as part of a full digital transformation program, MATRIXX Digital Commerce Platform enables TPG Telecom to be more commercially competitive, while also reducing costs associated with legacy infrastructure.
“We started with the ambition to consolidate multiple mobile rating platforms whilst still operating as Vodafone Hutchison Australia. Having merged with TPG Corporation to form TPG Telecom, using MATRIXX has further enabled us to ensure all our brands have access to a common rating platform. MATRIXX allows us to consolidate and transform 4G and 5G service monetization by moving to a single real-time platform that’s tightly integrated with our network,” said Easwaren Siva, General Manager Strategy & Architecture of TPG Telecom.
With the first phase completed, MATRIXX is now live for Vodafone branded prepaid services. Later phases of the transformation program will see TPG Telecom migrating mobile postpaid rating across their portfolio of brands, in addition to MVNO, wholesale and enable Standalone 5G charging.
“We are thrilled to be able to help bring TPG Telecom’s vision of improved commercial agility and greater customer experience,” said Glo Gordon, MATRIXX CEO. “Helping to transform how TPG Telecom monetizes today, while giving them a powerful and highly configurable monetization platform for their future innovation, speaks to the core of what we do best — empowering our customers, so that they can empower theirs.”
About TPG Telecom
TPG Telecom Limited was formed by the merger of Vodafone Hutchison Australia Pty Limited and TPG Corporation, formerly named TPG Telecom, on 13 July 2020. The merger brought together two highly complementary businesses, creating the leading challenger full-service telecommunications provider in Australia.
About MATRIXX Software
MATRIXX Software is the global leader in 5G monetization for the communications industry. Serving many of the world’s largest operator groups, regional carriers, and emerging digital service providers, MATRIXX delivers a cloud native digital commerce solution that enables unmatched commercial and operational agility. Unifying IT & networks, MATRIXX delivers a network-grade converged charging system (CCS) enabling efficient hyper-scaling of infrastructure to support consumer services, wholesale and enterprise marketplaces. Through its relentless commitment to product excellence and customer success, MATRIXX empowers businesses to harness network assets and business agility to succeed at web scale.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210504005060/en/
Contact information
Jennifer Kyriakakis
mediainquiry@matrixx.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 15:00:00 EEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 15:00:00 EEST | Press release
ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful innovation to patients through technologies that advance precision, safety, and the overall treatment experience,” said Sheraz Daya, MD, Medical Director and Founder of Centre for Sight. “We are proud to be the first center globally
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 15:00:00 EEST | Press release
BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures and HEPATOMUNE® tri-cultures. Additionally, Christian Smith, Scientist I, R&D at BioIVT will present a poster titled "Therapeutic Reversal of Established Steatosis Usin
IHS Towers Publishes 2025 Sustainability Report26.5.2026 13:34:00 EEST | Press release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom